PHOENIX-OITB’s mission is to offer a Single-Entry-Point for a consolidated network of facilities, technologies, services and expertise for all the technology transfer aspects from characterization, testing, and verification up to scale-up, GMP-compliant manufacturing and regulatory guidance in the field of nanopharmaceuticals-development, framing the OITB clearly within the nanomedicine field.
The services and expertise provided by the PHOENIX-OITB include production and characterisation under GMP conditions, safety evaluation, regulatory compliance and commercialisation boost. The Open Call will offer funded services in the following categories:
in vitro Characterisation
in vivo Characterisation
Application period: 10 October 2022 – 31 January 2023 (first stage)
How to apply
Any legal entity (SMEs, start up or RTOs) and research group, based in the European Union or associate countries of H2020 can apply to this call.
The Evaluation Committee will evaluate each proposal in three main criteria:
The applicants will be informed about the decision made by the Evaluation Committee by the end of 01.03.2023 via email. A Stage 2 detailed application must then be submitted by 31.03.2023. Awarded projects must be completed by February 2025.
Potential applicants should read ALL supporting documents.
All application documents must be submitted by 31 Jan 2023 via email.
For any questions, please contact email@example.com